Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma
Clinical trial NCT01114555 · COMPLETED
Trial details
- NCT number
- NCT01114555
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-29
- Primary completion
- 2018-11-02
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.